Your browser doesn't support javascript.
loading
Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study.
Lipnicki, Darren M; Crawford, John D; Dutta, Rajib; Thalamuthu, Anbupalam; Kochan, Nicole A; Andrews, Gavin; Lima-Costa, M Fernanda; Castro-Costa, Erico; Brayne, Carol; Matthews, Fiona E; Stephan, Blossom C M; Lipton, Richard B; Katz, Mindy J; Ritchie, Karen; Scali, Jacqueline; Ancelin, Marie-Laure; Scarmeas, Nikolaos; Yannakoulia, Mary; Dardiotis, Efthimios; Lam, Linda C W; Wong, Candy H Y; Fung, Ada W T; Guaita, Antonio; Vaccaro, Roberta; Davin, Annalisa; Kim, Ki Woong; Han, Ji Won; Kim, Tae Hui; Anstey, Kaarin J; Cherbuin, Nicolas; Butterworth, Peter; Scazufca, Marcia; Kumagai, Shuzo; Chen, Sanmei; Narazaki, Kenji; Ng, Tze Pin; Gao, Qi; Reppermund, Simone; Brodaty, Henry; Lobo, Antonio; Lopez-Anton, Raúl; Santabárbara, Javier; Sachdev, Perminder S.
Afiliação
  • Lipnicki DM; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Crawford JD; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Dutta R; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Thalamuthu A; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Kochan NA; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Andrews G; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
  • Lima-Costa MF; Rene Rachou Research Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Castro-Costa E; Rene Rachou Research Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Brayne C; Department of Public Health and Primary Care, Cambridge University, Cambridge, United Kingdom.
  • Matthews FE; MRC Biostatistics Unit, Institute of Public Health, Cambridge, United Kingdom.
  • Stephan BC; Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Lipton RB; Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Katz MJ; Saul B. Korey Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, New York City, New York, United States of America.
  • Ritchie K; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Yeshiva University, New York City, New York, United States of America.
  • Scali J; Saul B. Korey Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, New York City, New York, United States of America.
  • Ancelin ML; Inserm, U1061 Neuropsychiatry: Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France.
  • Scarmeas N; Université de Montpellier, Montpellier, France.
  • Yannakoulia M; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
  • Dardiotis E; Inserm, U1061 Neuropsychiatry: Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France.
  • Lam LC; Université de Montpellier, Montpellier, France.
  • Wong CH; Inserm, U1061 Neuropsychiatry: Epidemiological and Clinical Research, La Colombière Hospital, Montpellier, France.
  • Fung AW; Université de Montpellier, Montpellier, France.
  • Guaita A; National and Kapodistrian University of Athens, Athens, Greece.
  • Vaccaro R; Columbia University, New York City, New York, United States of America.
  • Davin A; Harokopio University, Athens, Greece.
  • Kim KW; University of Thessaly, Larissa, Greece.
  • Han JW; Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Kim TH; Department of Psychiatry, Tai Po Hospital, Hong Kong SAR, China.
  • Anstey KJ; Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Cherbuin N; GolgiCenci Foundation, Abbiategrasso, Milan, Italy.
  • Butterworth P; GolgiCenci Foundation, Abbiategrasso, Milan, Italy.
  • Scazufca M; GolgiCenci Foundation, Abbiategrasso, Milan, Italy.
  • Kumagai S; Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Chen S; Department of Psychiatry, Seoul National University, College of Medicine, Seoul, Korea.
  • Narazaki K; Department of Brain and Cognitive Science, Seoul National University College of Natural Sciences, Seoul, Korea.
  • Ng TP; Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Gao Q; Department of Psychiatry, Yonsei University Wonju Severance Christian Hospital, Wonju, Korea.
  • Reppermund S; Centre for Research on Ageing, Health and Wellbeing, College of Medicine, Biology and Environment, The Australian National University, Canberra, Australia.
  • Brodaty H; Centre for Research on Ageing, Health and Wellbeing, College of Medicine, Biology and Environment, The Australian National University, Canberra, Australia.
  • Lobo A; Centre for Research on Ageing, Health and Wellbeing, College of Medicine, Biology and Environment, The Australian National University, Canberra, Australia.
  • Lopez-Anton R; Institute of Psychiatry and LIM-23, Clinics Hospital, University of São Paulo, São Paulo, Brazil.
  • Santabárbara J; Faculty of Arts and Science, Kyushu University, Kasuga City, Japan.
  • Sachdev PS; Xiangya School of Nursing, Central South University, Changsha, China.
PLoS Med ; 14(3): e1002261, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28323832
ABSTRACT

BACKGROUND:

The prevalence of dementia varies around the world, potentially contributed to by international differences in rates of age-related cognitive decline. Our primary goal was to investigate how rates of age-related decline in cognitive test performance varied among international cohort studies of cognitive aging. We also determined the extent to which sex, educational attainment, and apolipoprotein E ε4 allele (APOE*4) carrier status were associated with decline. METHODS AND

FINDINGS:

We harmonized longitudinal data for 14 cohorts from 12 countries (Australia, Brazil, France, Greece, Hong Kong, Italy, Japan, Singapore, Spain, South Korea, United Kingdom, United States), for a total of 42,170 individuals aged 54-105 y (42% male), including 3.3% with dementia at baseline. The studies began between 1989 and 2011, with all but three ongoing, and each had 2-16 assessment waves (median = 3) and a follow-up duration of 2-15 y. We analyzed standardized Mini-Mental State Examination (MMSE) and memory, processing speed, language, and executive functioning test scores using linear mixed models, adjusted for sex and education, and meta-analytic techniques. Performance on all cognitive measures declined with age, with the most rapid rate of change pooled across cohorts a moderate -0.26 standard deviations per decade (SD/decade) (95% confidence interval [CI] [-0.35, -0.16], p < 0.001) for processing speed. Rates of decline accelerated slightly with age, with executive functioning showing the largest additional rate of decline with every further decade of age (-0.07 SD/decade, 95% CI [-0.10, -0.03], p = 0.002). There was a considerable degree of heterogeneity in the associations across cohorts, including a slightly faster decline (p = 0.021) on the MMSE for Asians (-0.20 SD/decade, 95% CI [-0.28, -0.12], p < 0.001) than for whites (-0.09 SD/decade, 95% CI [-0.16, -0.02], p = 0.009). Males declined on the MMSE at a slightly slower rate than females (difference = 0.023 SD/decade, 95% CI [0.011, 0.035], p < 0.001), and every additional year of education was associated with a rate of decline slightly slower for the MMSE (0.004 SD/decade less, 95% CI [0.002, 0.006], p = 0.001), but slightly faster for language (-0.007 SD/decade more, 95% CI [-0.011, -0.003], p = 0.001). APOE*4 carriers declined slightly more rapidly than non-carriers on most cognitive measures, with processing speed showing the greatest difference (-0.08 SD/decade, 95% CI [-0.15, -0.01], p = 0.019). The same overall pattern of results was found when analyses were repeated with baseline dementia cases excluded. We used only one test to represent cognitive domains, and though a prototypical one, we nevertheless urge caution in generalizing the results to domains rather than viewing them as test-specific associations. This study lacked cohorts from Africa, India, and mainland China.

CONCLUSIONS:

Cognitive performance declined with age, and more rapidly with increasing age, across samples from diverse ethnocultural groups and geographical regions. Associations varied across cohorts, suggesting that different rates of cognitive decline might contribute to the global variation in dementia prevalence. However, the many similarities and consistent associations with education and APOE genotype indicate a need to explore how international differences in associations with other risk factors such as genetics, cardiovascular health, and lifestyle are involved. Future studies should attempt to use multiple tests for each cognitive domain and feature populations from ethnocultural groups and geographical regions for which we lacked data.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Escolaridade / Disfunção Cognitiva / Genótipo Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apolipoproteínas E / Escolaridade / Disfunção Cognitiva / Genótipo Idioma: En Ano de publicação: 2017 Tipo de documento: Article